ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard

April 22, 2011

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

Simone Replaces Levine As Cancer Policy Board Chairman

April 19, 2002